ReCode Therapeutics
ReCode Therapeutics is seeking a Senior Research Associate to conduct laboratory experiments supporting the development of scalable LNP-encapsulated nucleic acid formulations and manufacturing processes. The role involves lab-scale process development, scale‑up, in‑process characterization, and collaboration with a diverse team of scientists in the RNA therapeutics field.
Headquarters
Durham, North Carolina, United States
Company Size
11-50 employees
Founded
2015
ReCode Therapeutics is a genetic medicines company focused on delivery-first platforms that enable highly targeted delivery of therapeutic mRNA and gene-correction payloads to organs, tissues, and cell types beyond the liver. Their pipeline targets rare diseases using optimized mRNA and gene correction approaches designed with redosing capability. By prioritizing superior, tissue-targeted delivery, ReCode aims to broaden the clinical reach and durability of genetic medicines across non‑hepatic tissues.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ReCode Therapeutics.
7% below the average for this role